Author: admin

Integral Molecular to Advance Vaccine Discovery with NIH Contract for $5.5M

PHILADELPHIA – (PR NEWSWIRE) – The National Institute of Allergy and Infectious Diseases (NIAID) has awarded Integral Molecular a contract (75N93019C00073) which will provide […]

Philadelphia’s Integral Molecular Opens New Research Center in Response to Upsurge in Antibody Discovery Partnerships

PHILADELPHIA – (PR NEWSWIRE) – Integral Molecular, the industry leader in membrane protein solutions, has expanded its research facility to a second location to […]

Integral Molecular Selected as the First Industry Partner in The Wistar Institute’s Biomedical Research Technician Apprenticeship

PHILADELPHIA ¬ Sept. 26, 2019 — Integral Molecular, Inc. has been selected by The Wistar Institute, a global leader in cancer, immunology and infectious […]

Integral Molecular and Penn Medicine Collaborate on Autoimmune Encephalitis Target Discovery

Integral Molecular is announcing a new collaboration with the Perelman School of Medicine at the University of Pennsylvania (Penn). Integral Molecular and Penn will […]

Integral Molecular Presents Data on Monoclonal Antibodies (MAbs) Against SLC2A4 (GLUT4), a Critical Target for Diabetes

PHILADELPHIA -(PR NEWSWIRE)- Integral Molecular, the industry leader in discovering antibodies against multipass membrane proteins, recently presented data at the American Diabetes Association’s Annual […]

Integral Molecular Reaches Milestone in Immuno-Oncology Target Discovery Collaboration with Daiichi Sankyo

PHILADELPHIA -(PR Newswire)- Integral Molecular, the industry leader in discovering antibodies against multipass membrane proteins, today announced that it has successfully reached the first […]

Integral Molecular Doubles Antibody Characterization Capacity Within Philadelphia’s Science Center

PHILADELPHIA-(PR NEWSWIRE)-Integral Molecular, the industry leader in membrane protein solutions, today announced the expansion of its two proprietary antibody characterization platforms, Shotgun Mutagenesis Epitope […]

Integral Molecular to Present Claudin 6 MAbs, a Therapeutic Asset for Solid Tumors, at Annual AACR Conference

PHILADELPHIA–Integral Molecular, the industry leader in discovering antibodies against multipass membrane proteins, will showcase updated data on its discovery of highly specific Claudin 6 […]

Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes

FOX, ET AL. 2019. SCI IMMUNOL, 4(32): EAAV5062 Read More […]